Malaria vaccine difficult to roll out because four doses are needed, WHO says

A Gulland - 2015 - bmj.com
A phase III trial showed that the RTS, S vaccine, which acts against Plasmodium falciparum,
had an efficacy of around 30%. 1 The vaccine, which is most effective in children aged …

Malaria vaccine difficult to roll out because four doses are needed, WHO says

A Gulland - 2015 - bmj.com
A phase III trial showed that the RTS, S vaccine, which acts against Plasmodium falciparum,
had an efficacy of around 30%. 1 The vaccine, which is most effective in children aged …

[引用][C] Malaria vaccine difficult to roll out because four doses are needed, WHO says

A Gulland - BMJ (Clinical research ed.), 2015 - pubmed.ncbi.nlm.nih.gov

[引用][C] Malaria vaccine difficult to roll out because four doses are needed, WHO says.

A Gulland - BMJ (Clinical Research ed.), 2015 - europepmc.org
Malaria vaccine difficult to roll out because four doses are needed, WHO says. - Abstract -
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …

Malaria vaccine difficult to roll out because four doses are needed, WHO says

A Gulland - BMJ: British Medical Journal (Online), 2015 - search.proquest.com
A phase III trial showed that the RTS, S vaccine, which acts against Plasmodium falciparum,
had an efficacy of around 30%. 1 The vaccine, which is most effective in children aged …